Company Filing History:
Years Active: 2011-2013
Title: Innovations in Cancer Treatment by I-Chung Tang
Introduction
I-Chung Tang is a notable inventor based in Pingjhen, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, his work focuses on the development of radioactive materials that can effectively inhibit cancer.
Latest Patents
One of his latest patents is titled "Radioactive material containing chitosan for inhibiting cancer and preparation method thereof." This invention reveals a radioactive material formed by using a SOCTA chelating agent to connect chitosan with radionuclides such as Re and Tc-99m. The preparation method involves creating a SOCTA-Chitosan compound and subsequently forming an M(radionuclide)-SOCTA-Chitosan compound. The biocompatibility of chitosan allows the radioactive material to be injected into cancerous areas, providing effective treatment by remaining in the body for an extended period.
Another significant patent is "Radioactive mixture and manufacturing method thereof." This invention discloses a radioactive mixture formed through a chelating reaction of MN series compounds with TcO or ReO, which is then dissolved in Lipiodol. This mixture is designed to treat liver cancers, breast cancers, and other solid tumors while minimizing injuries caused by surgical operations. The innovative use of Re-188 MN or Re-188 MN/Lipiodol can also be combined with anticancer drugs and other therapeutic modalities.
Career Highlights
I-Chung Tang is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he continues to advance his research in nuclear medicine and cancer treatment. His work has garnered attention for its potential to improve patient outcomes in oncology.
Collaborations
I-Chung Tang collaborates with Kwei-Luen Hsu, contributing to the development of innovative solutions in cancer therapy.
Conclusion
I-Chung Tang's contributions to cancer treatment through his innovative patents highlight the importance of research in improving medical therapies. His work exemplifies the potential of combining biocompatible materials with radioactive elements to create effective treatment options for cancer patients.